Know Cancer

or
forgot password

A Randomised, Double-blind, Placebo-controlled, Three-way Cross-over Single Center Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)


Phase 0
18 Years
80 Years
Not Enrolling
Both
Morton's Neuroma

Thank you

Trial Information

A Randomised, Double-blind, Placebo-controlled, Three-way Cross-over Single Center Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)


A randomised, double-blind, placebo-controlled, three-way cross-over single center study to
characterize the phenotype in patients with Morton's Neuroma and to explore the effect of
local administration of Xylocaine (lidocaine)


Inclusion Criteria:



- Patients with a clinical diagnosis of Morton's neuroma with symptoms of at least 3
months duration in one foot (affected foot)

- Visual analogue scale (VAS) pain-score of = 40 mm in the painful foot at daily
activities during the previous week (visit 1)

Exclusion Criteria:

- Allergy to lidocaine

- Scars or other dermal conditions on the feet that may interfere with study procedures

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Outcome Measure:

The baseline phenotypic Quantitative sensory testing (QST) variables (e.g. heat, cold, touch and mechanical pain perception). Sensory tests will be performed to measure pain and skin sensitivity by use of different pressure (mN) and temperature ( C)

Outcome Time Frame:

Before and after drug injection at Day 1

Safety Issue:

No

Principal Investigator

Bror Jonzon, MD, PhD

Investigator Role:

Study Director

Investigator Affiliation:

AstraZeneca R&D Södertälje, Sweden

Authority:

Sweden: Medical Products Agency

Study ID:

D2285M00032

NCT ID:

NCT01298310

Start Date:

February 2011

Completion Date:

May 2012

Related Keywords:

  • Morton's Neuroma
  • Morton's neuroma, QST measurements
  • Neuroma

Name

Location